chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received her vaccine on Thursday, 1/21/21.  From then until Saturday afternoon she had been experiencing extreme fatigue.  On Sat. around 5:00 PM she was standing at her flat-top stove cooking dinner.   A wave of very extreme fatigue came over her, so she leaned over to turn off the burner.  When she did this, she passed out leaning forward with her hand on the burner and touching the frying pan.  When she came to, she went to the couch and laid down - not realizing for 10 minutes that her hand and right breast were burned.   The resulting injuries lead to her having to see her PCP on Monday, and then a General Surgeon on Weds 1/27/21.   Injuries sustained include a second degree burn on her right breast, On the right arm, laterally above the wrist is a small superficial partially healed burn.  On the dorsal aspect of the right fifth finger there is a longitudinal burn that goes from the MCP joint to almost the tip of the finger.  She has limited range of motion due to discomfort and swelling.  The blister encompasses the entire dorsal lateral aspect of the finger. The fourth right finger has a less extensive blistered area on the PIP joint.   The burn on the fifth finger is  deep second degree.
1.5 inch circle red raised circle at injection site started morning of 3/12/21.
redness at injection site; warmth at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site erythema and injection site warmth were resolved with sequelae.   It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to Shingrix.  Additional case details were provided as follows: The patient reported for herself. The patient developed redness and warmth at the injection site after receiving Shingrix. She disconnected the call before providing mailing address, date of birth or any additional details regarding event. For tolerance after 2nd dose refer case US2019178944. The case US2019AMR179518 has been identified as duplicate of  US2019178944, will be deleted.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterates that because facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec 2021, Jan 2022, and Feb 2022. They were filling out a temperature excursion assessment with the State at that time. It was reported that no adverse reactions were reported by any patients. No treatment medications were reported.   This case was linked to MOD-2022-501575 (Patient Link).
COVID arm; Had diffuse rash after getting the Moderna COVID vaccine / rash all over the body lasting for weeks; This spontaneous case was reported by a physician and describes the occurrence of IMMUNISATION REACTION (COVID arm) and RASH (Had diffuse rash after getting the Moderna COVID vaccine / rash all over the body lasting for weeks) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (COVID arm) and RASH (Had diffuse rash after getting the Moderna COVID vaccine / rash all over the body lasting for weeks). At the time of the report, IMMUNISATION REACTION (COVID arm) and RASH (Had diffuse rash after getting the Moderna COVID vaccine / rash all over the body lasting for weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to US-MODERNATX, INC.-MOD-2021-624139, US-MODERNATX, INC.-MOD-2021-624209 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-624139:80 year old patient case US-MODERNATX, INC.-MOD-2021-624209:Case for couple of patients
Starting the night after receiving the vaccine, I had a syncopal event that happened. I experienced diarrhea, nausea and vomiting and fever. These symptoms lasted for 3 days. 14 days later, the arm with the injection site swelled up, was sore and red for about a week then went away.
Myalgia  on January 21st the patient has aches and chills and in the morning the  patient felt bad and passed out and hit her head on the counter Narrative:  Patient awoke and found herself in a pool of blood and had  a significant cut on her head. The patient had to see care at an urgent care and required four staples.   Other Relevant History:
pt recv vax 28AUG95 & 5SEP95 devel nausea, vomiting, & t102-103 x3 days;also exp gen aching & a cough;cough worsened as the wk progressed;pt seen @ clinic & placed on Bactrim;
Injection was given too high into the shoulder.  I have pics.  4 hours later couldn?t move my arm.  Severe shoulder pain that night.   Iced/600 ibuprofen used.  One hydracodine used next night.  Exercises provided by doctor.  Mobility still limited.  Still pain with certain movements.  Started seeing Physical Therapist July 21. Will see weekly to see if it improves.
We administered the pediatric Pfizer without mixing it with diluent first.  So far the patient has no side effects.
SORE ARM: March 5 at 7:00 pm - vaccination site on left arm started to feel sore. Lasted about 24 hours and then was gone. No treatment needed.   SWOLLEN LYMPH NODES: March 8 at 7:00 pm - felt a pop in right ear that felt like an earache accompanied by pain, which slowly traveled down under the jawline between ear and chin. Visibly swollen and painful lymph nodes under the jaw for the next 30 hours, then it went away.  Advil didn't help with the pain, no other treatment.   REACTION AT VACCINATION SITE:  March 12 - vaccination site on left arm itchy all day. Looked at it at 11:00 pm and it was about a 3" itchy red circle around the vaccination site that was raised and hard, and emanating heat. Put aloe vera on it each morning and night.   Got about an inch larger over the next two days. Continued to emanate heat, less itchy.   March 14 at 11:00 pm - no longer a red circle, now the border was white but the center was normal. Was gone by the morning of March 15.
Patient reports pain beginning from trapezoid muscle at base of neck down into left arm, with worst pain in left deltoid area. She also reports the pain radiates into her mid back on her left side. She is unable to get her arm in a comfortable position, and it hurts when she coughs.
Headache, all over body ache, fatigue, lost of appetite-flu like symptoms lasted 5 days.
muscles aches, chills, severe headache,  dizziness, nauseous,  sore throat
Chills x 24 hours, felt feverish, hives onset 01/21/2021
shortly after being vaccinated, member c/o throat itchiness, and feeling uneasy similar to allergic reactions to the shingles vaccine 1-2 years ago.
In late March/ April, patient started having dizziness and unsteady gait. Heart work up good. Not better with steroids. N/V by July. September MRI brain showed 4th ventricle mass, ependymoma, required brain surgery.
NO ADVERSE EVENTS REPORTED. PT IS UNDERAGE AND REPORTED TO US AS 12YO , PT IS REALLY 11YO
I experienced dizziness, nausea, disorientation and fainted while standing.  I hurt my head, knee and thumb, but was otherwise ok.  I don't know how long I was out and woke up on the floor.    :(
pt recv vax 12JAN96 & fell asleep & woke up crying & gasping for air;pt had inconsolable crying for 4-5 hr;pt taken to ER & recovered a/left;this is 1 of 4 pt from this site & lot# to report adverse rxn;
(2nd report) 2 days after getting shingles vaccine: chills, fever, low back pain, incontinence. Ran it's course but exhausted. On 3/29 blood work showed hyperthyroidism - I had never ever had that. It has been difficult from the springtime, to continued exhaustion  to irreg. heartbeat to lack of energy to do daily chores or get involved w/community. Have never regained health level prior to  3/6/09.
Numbing and tingling sensation in my thumb, pointer, and middle finger of my right hand.; Numbing and tingling sensation in my thumb, pointer, and middle finger of my right hand.; This is a spontaneous report from a contactable consumer (patient). A 39-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported, Expiry date not reported) via an unspecified route of administration in Arm Right on 13Mar2021 11:00 (at the age of 39 years old) as dose 2, single for COVID-19 immunization. Medical history included bipolar 2 disorder, allergy to penicillin. Patient was not tested for COVID post vaccination Concomitant medication taken within two weeks of COVID vaccine included ibuprofen (IBUPROFEN) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported, Expiry date not reported) via an unspecified route of administration in Arm Left on 20Feb2021 11:00 (at the age of 38 years old) as dose 1, single for COVID-19 immunization. Patient did not receive other vaccine in four weeks of COVID vaccine. The patient experienced numbing and tingling sensation in my thumb, pointer, and middle finger of my right hand on 13Mar2021 11:45. No treatment were received for the adverse events. Outcome of the events were unknown.  No follow up attempts are possible, information about lot/batch number cannot be obtained.
Patient has not reported adverse events at this time..was given a Pfizer peds that was not mixed so got a higher dose
Pt with significant left shoulder pain immediately after left deltoid vaccination. Progressive pain and restriction in motion. She was diagnosed with SIRVA and likely subacromial bursitis on day 5 after vaccination. Treated with home PT exercises and anti-inflammatory medications.
I had a rash and softball size swelling for a week. The rash itched, was tender to touch and hot feeling. The swelling went down after 5 days and the rash spread down to my elbow. Started out immediately as a quarter size bump and rash and got bigger and spread.
Local injection site pain resolved in normal fashion. After 2 weeks pt had pain radiating down to elbow. After 4 weeks pain was radiating to fingers. Would subside overnight and resume by afternoon, limiting pt ability to use arm. Pt has tried IBU with minimal success.
Febrile seizure-atypical.  Nurse follow up on 07/20/04 states: "febrile seizure, right otitis media."
My husband has had the vaccines and once again had shingles/suspected vacccination failure; Once again had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 4-June-2022 Reporter's comment: This case was reported by a patient's wife via interactive digital media. The patient had the vaccines and once again had shingles. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
3-4hrs. after vaccine received, experienced symptoms of: chest tightness, wheeze, dry scratchy throat, itchy swollen tongue, gums, swollen around eyes, increased heart rate, tired, dizzy. Took Benadryl.  4-6 after experience cold sweat and fever 100-101.
This child had vaccine failure. Varivax given on 07/11/00, in 12/00, the patient had chicken pox with over 100 lesions.
Patient was 2-3 weeks pregnant at time of vaccination. Possible birth defect caused fetal demise at 6 weeks 6 days of gestation. DNC was required.
patient had second shot and it hit hard; had a lot of pain and low-grade temperature; patient had second shot and it hit hard; had a lot of pain and low-grade temperature; This is a spontaneous report from a contactable consumer (patient) reported for self. A patient of unspecified age and gender received BNT162B2 (BNT162B2, Solution for injection PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE, 2 SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date patient had second shot and it hit hard; had a lot of pain and low-grade temperature and wanted to know to take anything (treatment) without doing any effect on the shot. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt slumped upon administering injection. RPh went to call 911, 2nd RPh went to observe pt/family. During this time mother said she had seizure, but when 2nd RPh got there she was coherent but pale. BP was unable to be read using cuff we had. EMS did take her to ER and mother called back to say she was fine. ER said most like vasovagal and not seizure.
muscle aches, right upper arm. tenderness at  the injection site.  headache, not relieved by  ibuprofen
He started throwing up again same as at 4 months.  His skin was very cold and when we took his temp it was 94 degrees.  His skin was ash gray and he was gasping for air.  In between episodes he had projectile vomiting.
Within 30 minutes post vax, the pt developed facial angioedema and urticaria. The pt presented to a physician and was treated in the usual manner and responded well. An allergist performed a local skin test because it was recommended that the pt be revaccinated with vax. The skin test showed a reaction and the allergist felt he should not administer the full dose to the pt.
severe rash; ITCH; BIG RED WALT; It is very hot; This spontaneous case was reported by a consumer and describes the occurrence of RASH (severe rash), PRURITUS (ITCH), INJECTION SITE ERYTHEMA (BIG RED WALT) and INJECTION SITE WARMTH (It is very hot) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced RASH (severe rash), PRURITUS (ITCH), INJECTION SITE ERYTHEMA (BIG RED WALT) and INJECTION SITE WARMTH (It is very hot). At the time of the report, RASH (severe rash), PRURITUS (ITCH), INJECTION SITE ERYTHEMA (BIG RED WALT) and INJECTION SITE WARMTH (It is very hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No concomitant drugs are provided.   Reporter did not allow further contact
Breakthrough case admission after 4 vaccines Moderna 3/3/21 Lot# 010A21A;  Moderna 3/31/21 Lot# 025B21A;  Moderna 11/24/21 Lot# 939903;  Moderna 5/19/22 Lot# Lot# 059M21A
couldn't stop shaking uncontrollably; soreness; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (couldn't stop shaking uncontrollably), PAIN (soreness) and FATIGUE (tiredness) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TREMOR (couldn't stop shaking uncontrollably), PAIN (soreness) and FATIGUE (tiredness). At the time of the report, TREMOR (couldn't stop shaking uncontrollably), PAIN (soreness) and FATIGUE (tiredness) outcome was unknown.            Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-065466 (Patient Link).
- Client was given LAIV, although history of asthma was checked, contraindicating LAIV. - No symptoms or signs or treatment.
Small area of right thigh felt like it was on fire. Day by day has spread to other areas of thigh. It started on inside of thigh and spread across the top day by day and each area continues to hurt. It's not a constant issue, but it comes and goes. Skin looks normal. Pt had to see MD about the pain. He was prescribed tramadol that has taken the edge off the pain. He is also taking ibuprofen. Taking both medications has helped a great deal. Patient still reports the issue spreading as of today 9/12/18. Patient will see his MD before his tramadol runs out. Patient stated that the MD thinks perhaps the shingles vaccine is messing with the nervous system-just a theory.
Dizziness, light headed, sharp pain in the chest all the way to the back., and shortness of breath
This spontaneous report as received from a Registered Nurse refers to multiple patients of unknown ages and genders. Medical history and current conditions were not reported. On an unknown dates over an unspecified 7 month period, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot number L037554, expiration date 25-DEC-2017, and lot number L016429, expiration date 09-AUG-2017. Dose and route of administration were not provided. No other suspect or concomitant medications were reported. As reported, temperature: uncertain, surmising worst case 51 Fahrenheit degrees for 7 months; digital data logger was involved. Previous: uncertain. No adverse effects were reported. Lot number L037554 is an invalid lot number for GARDASIL 9. This is one of four reports received from the same reporter. Additional information has been requested.
1/22/22  Request lab only visit due to cost  Immunized but not boosted 3/24/21 and 4/14/21 Never had COVID Roommate positive but they are staying on opposite floors Today has runny/stuffy nose, HA, lightly scratchy thorat     Low risk with age, no comorbidities Immunized, not boosted
Information has been received from a consumer concerning her neighbors son, who was 17 years old at the time of the report, and was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live, in approximately 1990. Subsequently the patient developed autism. No further information was available. There was no product quality complaint involved. Upon internal review, Autism was considered to be an other important medical event (OMIC). Additional information has been requested.
contracted covid after first dose Narrative: First covid vaccine dose 12/31/2020, tested positive for covid 1/7/2021, died from complications 1/25/2021
Low grade fever and Fatigue. Treated with Ibuprofen and rest. Lasted 12 hours
Blood pressure really high after first dose of COVID vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; cabozantinib (CABOMETYX), first regimen (Batch/Lot number: unknown) at 40 mg 1x/day (40 mg, qd) and second regimen (Batch/Lot number: unknown) at 60 mg 1x/day (60 mg, qd). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLOOD PRESSURE INCREASED (non-serious), outcome "unknown", described as "Blood pressure really high after first dose of COVID vaccine". Relevant laboratory tests and procedures are available in the appropriate section. The action taken for cabozantinib was unknown.  Additional information:The patient received the first dose of Cabometyx 60 mg, qd (route of administration is not reported). On an unknown date, the patient started decrease dose at Cabometyx 40 mg, qd (route of administration not provided). The date of the most recent dose of Cabometyx prior to the event was not reported. Initially, during Cabometyx therapy, patient's blood pressure had been maintained to normal level. Further, on an unknown date, the patient experienced blood pressure high (blood pressure increased) after first dose of COVID vaccine. The reporter did not provide causality assessment for blood pressure increased with respect to Cabometyx.  The lot number for bnt162b2 was not provided and will be requested during follow up.